Literature DB >> 34017010

DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set.

Damir Vrabac1, Akshay Smit1, Sebastian Fernandez-Pol2, Pranav Rajpurkar3, Rebecca Rojansky2, Yasodha Natkunam2, Ranjana H Advani4, Andrew Y Ng1.   

Abstract

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. Though histologically DLBCL shows varying morphologies, no morphologic features have been consistently demonstrated to correlate with prognosis. We present a morphologic analysis of histology sections from 209 DLBCL cases with associated clinical and cytogenetic data. Duplicate tissue core sections were arranged in tissue microarrays (TMAs), and replicate sections were stained with H&E and immunohistochemical stains for CD10, BCL6, MUM1, BCL2, and MYC. The TMAs are accompanied by pathologist-annotated regions-of-interest (ROIs) that identify areas of tissue representative of DLBCL. We used a deep learning model to segment all tumor nuclei in the ROIs, and computed several geometric features for each segmented nucleus. We fit a Cox proportional hazards model to demonstrate the utility of these geometric features in predicting survival outcome, and found that it achieved a C-index (95% CI) of 0.635 (0.574,0.691). Our finding suggests that geometric features computed from tumor nuclei are of prognostic importance, and should be validated in prospective studies.

Entities:  

Year:  2021        PMID: 34017010     DOI: 10.1038/s41597-021-00915-w

Source DB:  PubMed          Journal:  Sci Data        ISSN: 2052-4463            Impact factor:   6.444


  12 in total

Review 1.  Germinal centres and B cell lymphomagenesis.

Authors:  Katia Basso; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2015-03       Impact factor: 53.106

2.  Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.

Authors:  Ash A Alizadeh; Andrew J Gentles; Alvaro J Alencar; Chih Long Liu; Holbrook E Kohrt; Roch Houot; Matthew J Goldstein; Shuchun Zhao; Yasodha Natkunam; Ranjana H Advani; Randy D Gascoyne; Javier Briones; Robert J Tibshirani; June H Myklebust; Sylvia K Plevritis; Izidore S Lossos; Ronald Levy
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

3.  Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Authors:  Gonzalo Gutiérrez-García; Teresa Cardesa-Salzmann; Fina Climent; Eva González-Barca; Santiago Mercadal; José L Mate; Juan M Sancho; Leonor Arenillas; Sergi Serrano; Lourdes Escoda; Salomé Martínez; Alexandra Valera; Antonio Martínez; Pedro Jares; Magdalena Pinyol; Adriana García-Herrera; Alejandra Martínez-Trillos; Eva Giné; Neus Villamor; Elías Campo; Luis Colomo; Armando López-Guillermo
Journal:  Blood       Date:  2011-03-25       Impact factor: 22.113

Review 4.  Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?

Authors:  Peter A Riedell; Sonali M Smith
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-12-24

5.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

6.  Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Authors:  John P Leonard; Kathryn S Kolibaba; James A Reeves; Anil Tulpule; Ian W Flinn; Tatjana Kolevska; Robert Robles; Christopher R Flowers; Robert Collins; Nicholas J DiBella; Steven W Papish; Parameswaran Venugopal; Andrew Horodner; Amir Tabatabai; Julio Hajdenberg; Jaehong Park; Rachel Neuwirth; George Mulligan; Kaveri Suryanarayan; Dixie-Lee Esseltine; Sven de Vos
Journal:  J Clin Oncol       Date:  2017-09-01       Impact factor: 44.544

7.  Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Authors:  Kai Fu; Dennis D Weisenburger; William W L Choi; Kyle D Perry; Lynette M Smith; Xinlan Shi; Christine P Hans; Timothy C Greiner; Philip J Bierman; R Gregory Bociek; James O Armitage; Wing C Chan; Julie M Vose
Journal:  J Clin Oncol       Date:  2008-07-28       Impact factor: 44.544

8.  Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

Authors:  Georg Lenz; George W Wright; N C Tolga Emre; Holger Kohlhammer; Sandeep S Dave; R Eric Davis; Shannon Carty; Lloyd T Lam; A L Shaffer; Wenming Xiao; John Powell; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph M Connors; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Lisa M Rimsza; Richard I Fisher; Dennis D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

9.  An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Authors:  Zheng Zhou; Laurie H Sehn; Alfred W Rademaker; Leo I Gordon; Ann S Lacasce; Allison Crosby-Thompson; Ann Vanderplas; Andrew D Zelenetz; Gregory A Abel; Maria A Rodriguez; Auayporn Nademanee; Mark S Kaminski; Myron S Czuczman; Michael Millenson; Joyce Niland; Randy D Gascoyne; Joseph M Connors; Jonathan W Friedberg; Jane N Winter
Journal:  Blood       Date:  2013-11-21       Impact factor: 22.113

10.  Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.

Authors:  David W Scott; Anja Mottok; Daisuke Ennishi; George W Wright; Pedro Farinha; Susana Ben-Neriah; Robert Kridel; Garrett S Barry; Christoffer Hother; Pau Abrisqueta; Merrill Boyle; Barbara Meissner; Adele Telenius; Kerry J Savage; Laurie H Sehn; Graham W Slack; Christian Steidl; Louis M Staudt; Joseph M Connors; Lisa M Rimsza; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

View more
  1 in total

1.  Deep Learning-Inferred Multiplex ImmunoFluorescence for Immunohistochemical Image Quantification.

Authors:  Parmida Ghahremani; Yanyun Li; Arie Kaufman; Rami Vanguri; Noah Greenwald; Michael Angelo; Travis J Hollmann; Saad Nadeem
Journal:  Nat Mach Intell       Date:  2022-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.